| License: Creative Commons Attribution 4.0 PDF - Published Version (746kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-452271
- DOI to cite this document:
- 10.5283/epub.45227
Alternative links to fulltext:Publisher
This publication is part of the DEAL contract with Springer.
Abstract
Comorbidity after allogeneic hematopoietic stem cell transplantation (alloHSCT) impairs quality of life (QoL), physical functioning, and survival. We developed a new standardized measure to capture comorbidity after transplantation, the Post-transplant Multimorbidity Index (PTMI) in a cohort of 50 long term survivors. We subsequently evaluated the content validity and impact on survival and QoL ...

Owner only: item control page

Download Statistics